Truist Securities lowered Elevance Health (NYSE:ELV) price target from $610 to $580
Truist Securities analyst Tobey Sommer maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $610 to $580.
Truist Securities lowered Elevance Health (NYSE:ELV) price target from $610 to $580 Read Post »